{"component": "clause", "props": {"groups": [{"snippet_links": [{"key": "principal-and-registered-office", "type": "clause", "offset": [146, 177]}], "samples": [{"hash": "iFAY40lYDvP", "uri": "/contracts/iFAY40lYDvP#formation-and-purpose", "label": "Operating Agreement (Insight Communications Co Inc)", "score": 18.0, "published": true}, {"hash": "gxtMfaHwgxa", "uri": "/contracts/gxtMfaHwgxa#formation-and-purpose", "label": "Operating Agreement (Insight Communications Co Inc)", "score": 18.0, "published": true}], "size": 6, "snippet": "2.1 Formation.......................................................13 2.2 Name............................................................13 2.3 Principal and Registered Office.................................14 2.4 Term............................................................14 2.5", "hash": "535759f83fa5e29c7033bd94f1d38440", "id": 4}, {"snippet_links": [{"key": "following-the-effective-date", "type": "clause", "offset": [9, 37]}, {"key": "the-parties-shall", "type": "clause", "offset": [39, 56]}, {"key": "the-committees", "type": "clause", "offset": [80, 94]}, {"key": "the-purpose", "type": "clause", "offset": [147, 158]}, {"key": "to-the-extent", "type": "clause", "offset": [183, 196]}, {"key": "both-parties-agree", "type": "clause", "offset": [219, 237]}, {"key": "to-defer", "type": "definition", "offset": [323, 331]}, {"key": "creation-of-the", "type": "clause", "offset": [336, 351]}, {"key": "one-party", "type": "definition", "offset": [368, 377]}, {"key": "other-party", "type": "definition", "offset": [390, 401]}, {"key": "the-parties-will", "type": "clause", "offset": [473, 489]}, {"key": "schedule-a", "type": "clause", "offset": [547, 557]}, {"key": "joint-steering-committee", "type": "definition", "offset": [606, 630]}, {"key": "fibroblast-program", "type": "definition", "offset": [666, 684]}, {"key": "on-a-quarterly-basis", "type": "definition", "offset": [852, 872]}, {"key": "review-and-approve", "type": "clause", "offset": [959, 977]}, {"key": "regulatory-committee", "type": "definition", "offset": [1083, 1103]}, {"key": "research-and-development-plans", "type": "clause", "offset": [1135, 1165]}, {"key": "regulatory-filings-and-correspondence", "type": "clause", "offset": [1207, 1244]}, {"key": "with-respect-to", "type": "clause", "offset": [1311, 1326]}, {"key": "the-foregoing", "type": "clause", "offset": [1327, 1340]}, {"key": "commercialization-committee", "type": "definition", "offset": [1342, 1369]}, {"key": "activities-under", "type": "clause", "offset": [1469, 1485]}, {"key": "intellectual-property-committee", "type": "definition", "offset": [1510, 1541]}, {"key": "intellectual-property-issues", "type": "clause", "offset": [1559, 1587]}, {"key": "in-connection-with", "type": "clause", "offset": [1588, 1606]}, {"key": "pursuant-to-a", "type": "definition", "offset": [1754, 1767]}, {"key": "request-for-confidential-treatment", "type": "definition", "offset": [1768, 1802]}, {"key": "under-rule", "type": "clause", "offset": [1803, 1813]}, {"key": "securities-exchange-act-of-1934", "type": "definition", "offset": [1827, 1858]}, {"key": "as-amended", "type": "definition", "offset": [1860, 1870]}, {"key": "complete-copy", "type": "definition", "offset": [1874, 1887]}, {"key": "filed-separately-with-the-securities-and-exchange-commission", "type": "clause", "offset": [1914, 1974]}], "samples": [{"hash": "FqP4X806I2", "uri": "/contracts/FqP4X806I2#formation-and-purpose", "label": "Exclusive Channel Collaboration Agreement (Castle Creek Biosciences, Inc.)", "score": 32.5373039246, "published": true}, {"hash": "21YulHc3wiS", "uri": "/contracts/21YulHc3wiS#formation-and-purpose", "label": "Exclusive Channel Collaboration Agreement (Castle Creek Biosciences, Inc.)", "score": 32.4031486511, "published": true}, {"hash": "1amo6onApO", "uri": "/contracts/1amo6onApO#formation-and-purpose", "label": "Exclusive Channel Collaboration Agreement (Fibrocell Science, Inc.)", "score": 24.2470912933, "published": true}], "size": 31, "snippet": "Promptly following the Effective Date, the Parties shall confer and then create the Committees listed in the chart below, each of which shall have the purpose indicated in the chart. To the extent that after conferring both Parties agree that a given Committee need not be created until a later date, the Parties may agree to defer the creation of the Committee until one Party informs the other Party of its then desire to create the so-deferred Committee, at which point the Parties will thereafter promptly create the so-deferred Committee and schedule a meeting of such Committee within one (1) month. Joint Steering Committee (\u201cJSC\u201d) Establish projects for the Fibroblast Program and establish the priorities, as well as approve budgets for such projects. Approve all subcommittee projects and plans. The JSC shall establish budgets not less than on a quarterly basis. Chemistry, Manufacturing and Controls Committee (\u201cCMCC\u201d) Establish project plans and review and approve activities and budgets for chemistry, manufacturing, and controls under the Fibroblast Program. Clinical/Regulatory Committee (\u201cCRC\u201d) Review and approve all research and development plans, clinical projects and publications, and regulatory filings and correspondence under the Fibroblast Program; review and approve itemized budgets with respect to the foregoing. Commercialization Committee (\u201cCC\u201d) Establish project plans and review and approve activities and budgets for Commercialization activities under the Fibroblast Program. Intellectual Property Committee (\u201cIPC\u201d) Evaluate intellectual property issues in connection with the Fibroblast Program; review and approve itemized budgets with respect to the foregoing. Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission.", "hash": "f6af8794e9527c5dd7cfddace82a6cdf", "id": 1}, {"snippet_links": [{"key": "to-establish", "type": "definition", "offset": [18, 30]}, {"key": "joint-steering-committee", "type": "definition", "offset": [45, 69]}, {"key": "after-the-effective-date", "type": "clause", "offset": [94, 118]}, {"key": "consist-of", "type": "clause", "offset": [134, 144]}, {"key": "each-party", "type": "clause", "offset": [166, 176]}, {"key": "section-21", "type": "clause", "offset": [201, 212]}, {"key": "in-accordance-with", "type": "definition", "offset": [228, 246]}, {"key": "purpose-of-the", "type": "clause", "offset": [269, 283]}, {"key": "provide-a", "type": "definition", "offset": [300, 309]}, {"key": "overall-coordination", "type": "clause", "offset": [324, 344]}, {"key": "oversight-of-the-parties", "type": "clause", "offset": [364, 388]}, {"key": "activities-under-this-agreement", "type": "clause", "offset": [390, 421]}, {"key": "resolution-of-disputes", "type": "definition", "offset": [437, 459]}, {"key": "expiration-of-the-research-term", "type": "clause", "offset": [547, 578]}, {"key": "unless-otherwise-agreed", "type": "definition", "offset": [580, 603]}, {"key": "in-writing", "type": "clause", "offset": [604, 614]}, {"key": "by-the-parties", "type": "clause", "offset": [615, 629]}], "samples": [{"hash": "lrZhi7cgdiF", "uri": "/contracts/lrZhi7cgdiF#formation-and-purpose", "label": "License and Collaboration Agreement (Pandion Therapeutics Holdco LLC)", "score": 31.5297737122, "published": true}, {"hash": "eLlmZ11xzcT", "uri": "/contracts/eLlmZ11xzcT#formation-and-purpose", "label": "License and Collaboration Agreement (Pandion Therapeutics Holdco LLC)", "score": 31.4832305908, "published": true}, {"hash": "69PwJy5Yuvi", "uri": "/contracts/69PwJy5Yuvi#formation-and-purpose", "label": "License and Collaboration Agreement (Pandion Therapeutics Holdco LLC)", "score": 31.3874053955, "published": true}], "size": 10, "snippet": "The Parties agree to establish and convene a joint steering committee (the \u201cJSC\u201d) within [**] after the Effective Date. The JSC shall consist of representatives from each Party as further described in Section 2.1(d) and operate in accordance with this Section 2.1. The purpose of the JSC shall be to provide a forum for the overall coordination, communication and oversight of the Parties\u2019 activities under this Agreement, including the resolution of disputes properly referred to the JSC under this Agreement. The JSC shall be dissolved upon the expiration of the Research Term, unless otherwise agreed in writing by the Parties.", "hash": "7f6430cd68e89dd5cde1bb78777efbcc", "id": 2}, {"snippet_links": [{"key": "and-the-contractor", "type": "clause", "offset": [19, 37]}, {"key": "this-exhibit", "type": "definition", "offset": [49, 61]}, {"key": "attachment-i", "type": "definition", "offset": [65, 77]}, {"key": "by-authority", "type": "clause", "offset": [79, 91]}, {"key": "chapter-3", "type": "definition", "offset": [95, 104]}, {"key": "part-1", "type": "definition", "offset": [108, 114]}, {"key": "health-and-safety-code", "type": "clause", "offset": [137, 159]}, {"key": "approval-of-contractor", "type": "clause", "offset": [175, 197]}, {"key": "county-board-of-supervisors", "type": "definition", "offset": [200, 227]}, {"key": "for-the-purpose-of", "type": "definition", "offset": [242, 260]}, {"key": "alcohol-and-drug-services", "type": "clause", "offset": [271, 296]}, {"key": "pursuant-to-exhibit-a", "type": "clause", "offset": [324, 345]}, {"key": "standard-agreement", "type": "clause", "offset": [404, 422]}, {"key": "intergovernmental-agreement", "type": "clause", "offset": [452, 479]}, {"key": "to-confer", "type": "definition", "offset": [558, 567]}, {"key": "third-party", "type": "definition", "offset": [582, 593]}, {"key": "control-requirements", "type": "clause", "offset": [598, 618]}, {"key": "performance-under", "type": "clause", "offset": [622, 639]}, {"key": "terms-of", "type": "clause", "offset": [644, 652]}, {"key": "subject-to", "type": "clause", "offset": [686, 696]}, {"key": "applicable-federal-and-state-laws", "type": "clause", "offset": [701, 734]}, {"key": "and-standards", "type": "clause", "offset": [749, 762]}, {"key": "drug-and-alcohol", "type": "clause", "offset": [782, 798]}, {"key": "program-allocation", "type": "definition", "offset": [808, 826]}, {"key": "contractor-shall", "type": "clause", "offset": [870, 886]}, {"key": "to-establish", "type": "definition", "offset": [940, 952]}, {"key": "written-policies-and-procedures", "type": "clause", "offset": [954, 985]}, {"key": "consistent-with-the", "type": "clause", "offset": [986, 1005]}, {"key": "compliance-with-the", "type": "clause", "offset": [1047, 1066]}, {"key": "written-procedures", "type": "clause", "offset": [1067, 1085]}, {"key": "audit-exceptions", "type": "clause", "offset": [1121, 1137]}, {"key": "contractor-and-its-subcontractors", "type": "clause", "offset": [1164, 1197]}, {"key": "failure-to-comply-with", "type": "clause", "offset": [1206, 1228]}, {"key": "title-9", "type": "definition", "offset": [1306, 1313]}, {"key": "california-code-of-regulations", "type": "definition", "offset": [1315, 1345]}], "samples": [{"hash": "keVdEnUn5G1", "uri": "/contracts/keVdEnUn5G1#formation-and-purpose", "label": "Standard Agreement", "score": 26.5513820648, "published": true}, {"hash": "7A429jhXAHe", "uri": "/contracts/7A429jhXAHe#formation-and-purpose", "label": "Standard Agreement", "score": 26.5513820648, "published": true}, {"hash": "boJ1RaUi3w0", "uri": "/contracts/boJ1RaUi3w0#formation-and-purpose", "label": "Intergovernmental Agreement", "score": 25.5888442993, "published": true}], "size": 8, "snippet": "A. Authority State and the Contractor enter into this Exhibit A, Attachment I, by authority of Chapter 3 of Part 1, Division 10.5 of the Health and Safety Code (HSC) and with approval of Contractor\u2019s County Board of Supervisors (or designee) for the purpose of providing alcohol and drug services, which shall be reimbursed pursuant to Exhibit A, Attachment\nI. State and the Contractor identified in the Standard Agreement are the only parties to this Intergovernmental Agreement. This Intergovernmental Agreement is not intended, nor shall it be construed, to confer rights on any third party.\nB. Control Requirements\n1) Performance under the terms of this Exhibit A, Attachment I, is subject to all applicable federal and state laws, regulations, and standards. In accepting DHCS drug and alcohol combined program allocation pursuant to HSC Sections 11814(a) and (b), Contractor shall: (i) establish, and shall require its subcontractors to establish, written policies and procedures consistent with the following requirements; (ii) monitor for compliance with the written procedures; and (iii) be held accountable for audit exceptions taken by DHCS against the Contractor and its subcontractors for any failure to comply with these requirements:\na) HSC, Division 10.5, commencing with Section 11760; b) Title 9, California Code of Regulations (CCR) (herein referred to as Title 9), Division 4, commencing with Section 9000;", "hash": "5fb934dcb477490a9af2fc72238b080f", "id": 3}, {"snippet_links": [{"key": "following-the-effective-date", "type": "clause", "offset": [9, 37]}, {"key": "the-parties-shall", "type": "clause", "offset": [39, 56]}, {"key": "committee-shall", "type": "definition", "offset": [115, 130]}, {"key": "subject-to", "type": "clause", "offset": [147, 157]}, {"key": "paragraph-5", "type": "definition", "offset": [158, 169]}, {"key": "on-a-quarterly-basis", "type": "definition", "offset": [224, 244]}, {"key": "the-products", "type": "clause", "offset": [289, 301]}, {"key": "review-and-approve", "type": "clause", "offset": [306, 324]}, {"key": "regulatory-filings-and-correspondence", "type": "clause", "offset": [340, 377]}, {"key": "the-agreements", "type": "clause", "offset": [384, 398]}, {"key": "with-respect-to", "type": "clause", "offset": [451, 466]}, {"key": "the-foregoing", "type": "clause", "offset": [467, 480]}, {"key": "to-approve", "type": "clause", "offset": [483, 493]}, {"key": "the-projects", "type": "clause", "offset": [494, 506]}, {"key": "consistent-with", "type": "definition", "offset": [552, 567]}, {"key": "authority-and", "type": "clause", "offset": [573, 586]}, {"key": "either-party", "type": "definition", "offset": [610, 622]}, {"key": "key-employees", "type": "definition", "offset": [643, 656]}, {"key": "by-the-parties", "type": "clause", "offset": [666, 680]}, {"key": "transfer-services", "type": "definition", "offset": [696, 713]}, {"key": "technical-transfer-agreement", "type": "definition", "offset": [724, 752]}, {"key": "the-services", "type": "clause", "offset": [757, 769]}, {"key": "manufacturing-and-supply-agreement", "type": "clause", "offset": [780, 814]}], "samples": [{"hash": "56AIlTDgLvy", "uri": "/contracts/56AIlTDgLvy#formation-and-purpose", "label": "Technical Transfer and Service Agreement (Pacira BioSciences, Inc.)", "score": 37.1533203125, "published": true}, {"hash": "1P2Vl7WVEL3", "uri": "/contracts/1P2Vl7WVEL3#formation-and-purpose", "label": "Technical Transfer and Service Agreement (Pacira BioSciences, Inc.)", "score": 33.1587944031, "published": true}, {"hash": "19kjZiVQqNK", "uri": "/contracts/19kjZiVQqNK#formation-and-purpose", "label": "Technical Transfer and Service Agreement (Flexion Therapeutics Inc)", "score": 32.8631057739, "published": true}], "size": 5, "snippet": "Promptly following the Effective Date, the Parties shall confer and then create a Steering Committee. The Steering Committee shall have authority, subject to Paragraph 5, to oversee the priorities and budgets (not less than on a quarterly basis), to oversee manufacturing and controls for the Products, to review and approve all associated regulatory filings and correspondence under the Agreements (including reviewing and approving itemized budgets with respect to the foregoing), to approve the projects and plans of any subcommittee it establishes consistent with this authority and to review any concerns either Party may have concerning key employees employed by the Parties to provide the Transfer Services under the Technical Transfer Agreement and the Services under the Manufacturing and Supply Agreement.", "hash": "8dd30b6a0d14da1d2a6f726a568e6644", "id": 5}, {"snippet_links": [{"key": "exhibit-a", "type": "definition", "offset": [8, 17]}, {"key": "attachment-i", "type": "definition", "offset": [19, 31]}, {"key": "part-v", "type": "definition", "offset": [36, 42]}, {"key": "entered-into", "type": "clause", "offset": [62, 74]}, {"key": "the-state", "type": "clause", "offset": [90, 99]}, {"key": "and-the-contractor", "type": "clause", "offset": [100, 118]}, {"key": "for-the-purpose-of", "type": "definition", "offset": [119, 137]}, {"key": "services-for", "type": "clause", "offset": [180, 192]}, {"key": "substance-use-disorder-treatment", "type": "clause", "offset": [193, 225]}, {"key": "service-area", "type": "definition", "offset": [246, 258]}, {"key": "pursuant-to-sections", "type": "clause", "offset": [259, 279]}, {"key": "health-and-safety-code", "type": "clause", "offset": [306, 328]}, {"key": "title-22", "type": "definition", "offset": [444, 452]}, {"key": "california-code-of-regulations", "type": "definition", "offset": [460, 490]}, {"key": "it-is-further-agreed", "type": "clause", "offset": [573, 593]}, {"key": "this-contract", "type": "definition", "offset": [594, 607]}, {"key": "provisions-of", "type": "clause", "offset": [636, 649]}, {"key": "chapter-7", "type": "definition", "offset": [664, 673]}, {"key": "in-particular", "type": "clause", "offset": [700, 713]}, {"key": "not-limited", "type": "clause", "offset": [719, 730]}, {"key": "title-9", "type": "definition", "offset": [898, 905]}], "samples": [{"hash": "2EG6YLAlxzC", "uri": "/contracts/2EG6YLAlxzC#formation-and-purpose", "label": "Standard Agreement", "score": 26.6718254089, "published": true}, {"hash": "5QpKpFlCJ2U", "uri": "/contracts/5QpKpFlCJ2U#formation-and-purpose", "label": "County Contract", "score": 24.7785835266, "published": true}, {"hash": "iUSHOgMV8x6", "uri": "/contracts/iUSHOgMV8x6#formation-and-purpose", "label": "STD 213 Amendment", "score": 23.6827754974, "published": true}], "size": 5, "snippet": "A. This Exhibit A, Attachment I A1, Part V of the Contract is entered into by and between the State and the Contractor for the purpose of identifying and providing for covered DMC services for substance use disorder treatment in the Contractor\u2019s service area pursuant to Sections 11848.5(a) and (b) of the Health and Safety Code (hereinafter referred to as HSC), Sections 14124.20, 14021.51 \u2013 14021.53, and 14124.20 \u2013 14124.25 of the W&I , and Title 22 of the California Code of Regulations (hereinafter referred to as Title 22), Sections 51341.1, 51490.1, and 51516.1.\nB. It is further agreed this Contract is controlled by applicable provisions of: (a) the W&I, Chapter 7, Sections 14000, et seq., in particular, but not limited to, Sections 14100.2, 14021, 14021.5, 14021.6, 14043, et seq., (b) Title 22, including but not limited to Sections 51490.1, 51341.1 and 51516.1; and (c) Division 4 of Title 9 of the California Code of Regulations (hereinafter referred to as Title 9).", "hash": "2ee9747d465098b4b0595c2f3f881c52", "id": 6}, {"snippet_links": [{"key": "after-the-effective-date", "type": "clause", "offset": [9, 33]}, {"key": "the-parties-shall", "type": "clause", "offset": [35, 52]}, {"key": "joint-intellectual-property-committee", "type": "definition", "offset": [62, 99]}, {"key": "exchange-of-information-between-the-parties", "type": "clause", "offset": [131, 174]}, {"key": "to-the-extent", "type": "clause", "offset": [175, 188]}, {"key": "agreement-regarding", "type": "clause", "offset": [206, 225]}, {"key": "enforcement-of", "type": "clause", "offset": [259, 273]}, {"key": "licensed-patents", "type": "clause", "offset": [278, 294]}, {"key": "licensed-know", "type": "definition", "offset": [296, 309]}, {"key": "collaboration-patents", "type": "definition", "offset": [321, 342]}, {"key": "joint-inventions", "type": "definition", "offset": [378, 394]}, {"key": "the-membership", "type": "clause", "offset": [416, 430]}, {"key": "the-procedures", "type": "definition", "offset": [452, 466]}, {"key": "section-26", "type": "clause", "offset": [480, 491]}], "samples": [{"hash": "jkUNgHguNnz", "uri": "/contracts/jkUNgHguNnz#formation-and-purpose", "label": "Collaboration Agreement (Shire Pharmaceuticals Group PLC)", "score": 21.0, "published": true}, {"hash": "ciCAJ5aWkS5", "uri": "/contracts/ciCAJ5aWkS5#formation-and-purpose", "label": "Collaboration Agreement (Shire Pharmaceuticals Group PLC)", "score": 21.0, "published": true}, {"hash": "9OqNMrEva8r", "uri": "/contracts/9OqNMrEva8r#formation-and-purpose", "label": "Collaboration Agreement (New River Pharmaceuticals Inc)", "score": 21.0, "published": true}], "size": 5, "snippet": "Promptly after the Effective Date, the Parties shall create a joint intellectual property committee (the \u201cJIPC\u201d) to facilitate the exchange of information between the Parties to the extent required by this Agreement regarding the prosecution, maintenance and enforcement of the Licensed Patents, Licensed Know-How, Shire Collaboration Patents, Shire Collaboration Know-How, and Joint Inventions. The JIPC shall have the membership and shall operate by the procedures set forth in Section 2.6.", "hash": "afa019449a660297e1e2cdb23ed3e7f3", "id": 7}, {"snippet_links": [{"key": "after-the-effective-date", "type": "clause", "offset": [26, 50]}, {"key": "the-parties-shall", "type": "clause", "offset": [52, 69]}, {"key": "joint-development-committee", "type": "definition", "offset": [82, 109]}, {"key": "primary-function", "type": "definition", "offset": [147, 163]}, {"key": "development-plan-and-development-budget", "type": "clause", "offset": [233, 272]}, {"key": "the-product", "type": "definition", "offset": [277, 288]}, {"key": "progress-and-performance", "type": "clause", "offset": [300, 324]}, {"key": "amendments-to-the-development-plan", "type": "clause", "offset": [366, 400]}, {"key": "approval-by", "type": "clause", "offset": [428, 439]}], "samples": [{"hash": "IoyPO9KdzH", "uri": "/contracts/IoyPO9KdzH#formation-and-purpose", "label": "Co Development, Co Promotion, Marketing and Licensing Agreement", "score": 26.8904857635, "published": true}, {"hash": "6bT0qoAjGPY", "uri": "/contracts/6bT0qoAjGPY#formation-and-purpose", "label": "Co Development, Co Promotion, Marketing and Licensing Agreement", "score": 26.8904857635, "published": true}, {"hash": "b8dDTgqsBO4", "uri": "/contracts/b8dDTgqsBO4#formation-and-purpose", "label": "Collaboration Agreement (Orexigen Therapeutics, Inc.)", "score": 21.8405208588, "published": true}], "size": 5, "snippet": "Within [***] ([***]) days after the Effective Date, the Parties shall establish a joint development committee (the \u201cJDC\u201d), which shall perform the primary function of designing, implementing, monitoring, reviewing and discussing the Development Plan and Development budget for the Product, including progress and performance thereunder, and for proposing updates or amendments to the Development Plan and Development budget for approval by the JSC.", "hash": "8900851d500526b1278f98d9a66b3b96", "id": 8}, {"snippet_links": [{"key": "after-the-effective-date", "type": "clause", "offset": [9, 33]}, {"key": "the-parties-shall", "type": "clause", "offset": [35, 52]}, {"key": "joint-supply-committee", "type": "definition", "offset": [62, 84]}, {"key": "management-and-implementation", "type": "clause", "offset": [115, 144]}, {"key": "of-the-parties", "type": "clause", "offset": [145, 159]}, {"key": "with-regard-to", "type": "clause", "offset": [172, 186]}, {"key": "manufacture-and-supply-of-collaboration-products", "type": "clause", "offset": [191, 239]}, {"key": "the-membership", "type": "clause", "offset": [270, 284]}, {"key": "the-procedures", "type": "definition", "offset": [306, 320]}, {"key": "section-26", "type": "clause", "offset": [334, 345]}], "samples": [{"hash": "jkUNgHguNnz", "uri": "/contracts/jkUNgHguNnz#formation-and-purpose", "label": "Collaboration Agreement (Shire Pharmaceuticals Group PLC)", "score": 21.0, "published": true}, {"hash": "ciCAJ5aWkS5", "uri": "/contracts/ciCAJ5aWkS5#formation-and-purpose", "label": "Collaboration Agreement (Shire Pharmaceuticals Group PLC)", "score": 21.0, "published": true}, {"hash": "9OqNMrEva8r", "uri": "/contracts/9OqNMrEva8r#formation-and-purpose", "label": "Collaboration Agreement (New River Pharmaceuticals Inc)", "score": 21.0, "published": true}], "size": 5, "snippet": "Promptly after the Effective Date, the Parties shall create a joint supply committee (the \u201cJSC\u201d) to facilitate the management and implementation of the Parties\u2019 activities with regard to the Manufacture and supply of Collaboration Products worldwide. The JSC shall have the membership and shall operate by the procedures set forth in Section 2.6.", "hash": "21be85205f1a0e150fa40b4cbbc361bc", "id": 9}, {"snippet_links": [{"key": "after-the-effective-date", "type": "clause", "offset": [26, 50]}, {"key": "the-parties-shall", "type": "clause", "offset": [52, 69]}, {"key": "joint-manufacturing-committee", "type": "definition", "offset": [82, 111]}, {"key": "strategic-oversight", "type": "clause", "offset": [140, 159]}, {"key": "distribution-of-the-products", "type": "clause", "offset": [183, 211]}, {"key": "third-party-manufacturers", "type": "definition", "offset": [268, 293]}, {"key": "and-monitoring", "type": "clause", "offset": [295, 309]}, {"key": "the-production", "type": "clause", "offset": [310, 324]}, {"key": "production-capability", "type": "clause", "offset": [503, 524]}, {"key": "the-arrangements", "type": "clause", "offset": [587, 603]}, {"key": "distribution-of-products", "type": "clause", "offset": [612, 636]}, {"key": "as-specified", "type": "clause", "offset": [663, 675]}, {"key": "the-relevant", "type": "clause", "offset": [679, 691]}, {"key": "binding-order", "type": "clause", "offset": [692, 705]}], "samples": [{"hash": "IoyPO9KdzH", "uri": "/contracts/IoyPO9KdzH#formation-and-purpose", "label": "Co Development, Co Promotion, Marketing and Licensing Agreement", "score": 26.8904857635, "published": true}, {"hash": "6bT0qoAjGPY", "uri": "/contracts/6bT0qoAjGPY#formation-and-purpose", "label": "Co Development, Co Promotion, Marketing and Licensing Agreement", "score": 26.8904857635, "published": true}, {"hash": "b8dDTgqsBO4", "uri": "/contracts/b8dDTgqsBO4#formation-and-purpose", "label": "Collaboration Agreement (Orexigen Therapeutics, Inc.)", "score": 21.8405208588, "published": true}], "size": 5, "snippet": "Within [***] ([***]) days after the Effective Date, the Parties shall establish a joint manufacturing committee (the \u201cJMC\u201d) which will have strategic oversight of the manufacture and distribution of the Products including receiving updates from Orexigen regarding the Third Party Manufacturers, and monitoring the production capabilities of the Third Party Manufacturers in order that Takeda may forecast when Takeda demand for the Products in a given [***] exceed (or are likely to exceed) the maximum production capability of the Third Party Manufacturers in such [***] and overseeing the arrangements for the distribution of Products which are to be delivered as specified on the relevant binding order.", "hash": "7f354ccfd7406e67983787fd976d4949", "id": 10}], "next_curs": "Cl4SWGoVc35sYXdpbnNpZGVyY29udHJhY3RzcjoLEhZDbGF1c2VTbmlwcGV0R3JvdXBfdjU2Ih5mb3JtYXRpb24tYW5kLXB1cnBvc2UjMDAwMDAwMGEMogECZW4YACAA", "clause": {"title": "Formation and Purpose", "parents": [["scope-of-channel-collaboration-management", "Scope of Channel Collaboration Management"], ["committees", "Committees"], ["joint-steering-committee", "Joint Steering Committee"], ["governance", "Governance"], ["joint-development-committee", "Joint Development Committee"]], "size": 446, "children": [["purpose", "Purpose"], ["term", "Term"], ["name", "Name"], ["formation", "Formation"], ["registered-office-agent", "Registered Office/Agent"]], "id": "formation-and-purpose", "related": [["introduction-and-purpose", "Introduction and Purpose", "Introduction and Purpose"], ["scope-and-purpose", "Scope and Purpose", "Scope and Purpose"], ["parties-and-purpose", "Parties and Purpose", "Parties and Purpose"], ["intent-and-purpose", "INTENT AND PURPOSE", "INTENT AND PURPOSE"], ["authority-and-purpose", "Authority and Purpose", "Authority and Purpose"]], "related_snippets": [], "updated": "2026-04-02T05:40:27+00:00"}, "json": true, "cursor": ""}}